Moors & Cabot, Inc.
- SEC CIK
- 0001607239
- Latest filing
- Aug 10, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 55,165
- Value
- $4.99M
- % of portfolio
- 0.2%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 55,165 | $4.99M | 0.2% | +852+1.6% | Added | Holders |
| Q1 2026 | 54,313 | $4.35M | 0.2% | −959−1.7% | Reduced | Holders |
| Q4 2025 | 55,272 | $4.71M | 0.2% | +945+1.7% | Added | Holders |
| Q3 2025 | 54,327 | $4.23M | 0.2% | +578+1.1% | Added | Holders |
| Q2 2025 | 53,749 | $4.20M | 0.2% | +225+0.4% | Added | Holders |
| Q1 2025 | 53,524 | $3.88M | 0.2% | −1,065−2.0% | Reduced | Holders |
| Q4 2024 | 54,589 | $4.04M | 0.2% | +152+0.3% | Added | Holders |
| Q3 2024 | 54,437 | $3.59M | 0.2% | −75−0.1% | Reduced | Holders |
| Q2 2024 | 54,512 | $5.04M | 0.3% | +1,063+2.0% | Added | Holders |
| Q1 2024 | 53,449 | $5.11M | 0.3% | +2,950+5.8% | Added | Holders |
| Q4 2023 | 50,499 | $3.85M | 0.2% | +1,584+3.2% | Added | Holders |
| Q3 2023 | 48,915 | $3.39M | 0.2% | −705−1.4% | Reduced | Holders |
| Q2 2023 | 49,620 | $4.68M | 0.3% | +208+0.4% | Added | Holders |
| Q1 2023 | 49,412 | $4.09M | 0.3% | +652+1.3% | Added | Holders |
| Q4 2022 | 48,760 | $3.64M | 0.3% | +80+0.2% | Added | Holders |
| Q3 2022 | 48,680 | $4.02M | 0.3% | −1,572−3.1% | Reduced | Holders |
| Q2 2022 | 50,252 | $4.78M | 0.3% | −62−0.1% | Reduced | Holders |
| Q1 2022 | 50,314 | $5.92M | 0.4% | −1,025−2.0% | Reduced | Holders |
| Q4 2021 | 51,339 | $6.65M | 0.4% | −1,863−3.5% | Reduced | Holders |
| Q3 2021 | 53,202 | $6.02M | 0.4% | −322−0.6% | Reduced | Holders |
| Q2 2021 | 53,524 | $5.54M | 0.4% | +434+0.8% | Added | Holders |
| Q1 2021 | 53,090 | $4.44M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.